Scientists test One-Time brain injection to slow Alzheimer's
Disease control
Recruiting now
This is a first-in-human safety study testing a new gene therapy approach for early Alzheimer's disease and mild cognitive impairment. Researchers will use a harmless virus to deliver a protective protein called BDNF directly into the brain of 12 participants. The goal is to see …
Phase: PHASE1 • Sponsor: Mark Tuszynski • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC